• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Issues that matter
    • COVID-19 in India
    • Inadequate safe drinking water
    • Poor sanitation
    • Environmental health
    • Infectious disease
      • Hepatitis C
    • Noncommunicable Diseases (NCDs)
    • Malnutrition
    • High infant mortality
    • Mental health
    • Sex and gender discrimination
  • Special Focus
    • Interviews
      • Exclusive Interviews
      • Readers Interviews
    • Vaccine Hesitancy
  • News
  • PandemiCast
  • Partner’s Press Office

Health Issues India

Health issues in India

  • Home
  • About Us
  • Editorial Team
  • Subscribe
  • Contribute
  • Sponsor
  • Contact Us
You are here: Home / Featured / ‘Long COVID’ test devised by the University of Cambridge

‘Long COVID’ test devised by the University of Cambridge

July 21, 2021 By Nicholas Parry Leave a Comment

Share

Many questions have thus far been left unanswered regarding the COVID-19 pandemic. Foremost among these is the question of how will so-called ‘long COVID’ affect us in the future?

Confirmed cases of COVID-19 concept. a covid-19 blood test tube with result of positive on yellow background the X has clipping path and can be removed. COVID-19 testing concept. Antibody tests concept. Image credit: 罗 宏志 / 123rf. COVID-19 cases now number at one million: concept. Testing illustration. Symptomatic COVID-19 illustration. Cases of COVID-19 in India concept. COVID-19 clusters concept.. new covid-19 variant mutant strain long covid. COVID-19 cases concept. Even after recovery from COVID-19, long-COVID symptoms may persist. Image credit: 罗 宏志 / 123rf. B.1.617 concept. black fungus. Delta plus variant concern. Delta variant concept.
Image credit: 罗 宏志 / 123rf

There remain many unanswered questions. How many individuals have been affected by the disease and remained asymptomatic is all but unknown, as is the length of time that immunity lasts following infection — or even following vaccination. Adding to the concern, current tests are sometimes inaccurate under certain circumstances.

Antibody tests – which detect immune cells produced in response to infection – are estimated to miss around thirty percent of cases. This is more common in mild disease cases or after six months of initially contracting the virus. Many will be asymptomatic and so may never have been tested for the virus at all.

Scientists at the University of Cambridge hope to generate some answers to these questions. Dr Mark Wills from the Department of Medicine at the University of Cambridge, who co-leads the team, said “we need a reliable and objective way of saying whether someone has had COVID-19. Antibodies are one sign we look for, but not everyone makes a very strong response and this can wane over time and become undetectable.

“We’ve identified a cytokine that is also produced in response to infection by T cells and is likely to be detectable for several months – and potentially years – following infection. We believe this will help us develop a much more reliable diagnostic for those individuals who did not get a diagnosis at the time of infection.”

The cytokine test is hoped to be a means of diagnosing long COVID. Currently, due to the inaccuracy of antibody tests over long-term periods following infection, long COVID cannot be stated as a definitive diagnosis. Given the range of symptoms, this opens a potential diagnosis for a range of other conditions.

Dr Nyarie Sithole, who co-leads the team and helps to manage long COVID patients, said that “because we currently have no reliable way of diagnosing long COVID, the uncertainty can cause added stress to people who are experiencing potential symptoms. If we can say to them ‘yes, you have a biomarker and so you have long COVID’, we believe this will help allay some of their fears and anxieties.”

Health Issues India reported on long COVID symptoms earlier this year, citing a Lancet analysis which found 76 percent of patients reported at least one ongoing symptom. Long COVID has thus far been defined by the following symptoms, presenting themselves often many months following infection: fatigue, myalgia or inflammation, insomnia, and mental health impacts including anxiety. 

Commentators have warned of the dangers of post-traumatic stress disorder among those who have contracted COVID-19. The most common symptoms included fatigue or muscle weakness, reported by 63 percent; sleeping difficulties, reported by 26 percent; and anxiety or depression, reported by 23 percent.

Fatigue experienced by many that experience long COVID may be related to the tissue damage to the lungs. It is speculated that this potentially lasting damage relating to scarring of the lungs results in a chronic decrease in lung capacity. This is of particular concern as it may elevate the risks of lung conditions such as emphysema, lung cancer, or asthma. Given India’s numerous other elevated risk factors for lung conditions, such as high smoking rates and high levels of air pollution, these could combine to form a future public health crisis.

The tests are, however, in their initial stages. The pilot stage of the study saw the team recruit 85 patients to the Cambridge NIHR COVID BioResource, which collects blood samples from patients when they are first diagnosed with the virus, as well as at follow-up intervals over several months. They now hope to expand their cohort to 500 patients, recruited from Cambridgeshire and Peterborough.

These individuals will be followed up on for a period of eighteen months with the hopes of addressing the question of whether both antibodies, and the cytokine markers reduce over time. With this data, it can be determined how long immunity lasts post-infection. Answers to this question could be vital in informing vaccination campaigns in the future. Depending on the data, this could mean the difference between a single vaccination campaign or a yearly, flu-like vaccination drive that would require annual boosters. Such a prospect would be daunting, leaving us facing a costly, resource intensive fight still ahead to combat the COVID-19 as new variant strains become ever more of an issue.

Filed Under: Featured, Infectious diseases, Medicine and Research, News Tagged With: COVID-19, Long COVID

About Nicholas Parry

Nicholas Parry has a Bachelor of Science in genetics from the University of Sheffield and a Master of Research in neuroscience from the University of Nottingham. He has been a featured writer for Health Issues since 2016. He is based in South Wales.

Reader Interactions

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Articles

  • US declares monkeypox a public health emergency; The latest health stories from around the world
  • First Asian monkeypox death occurs in India
  • President Joe Biden tests positive for COVID-19 a second time; The latest health stories from around the world
  • Monkeypox officially declared a global emergency by WHO; The latest health stories from around the world
  • Four monkeypox cases now reported in India

Footer

Archives

Issues that matter

  • Environmental health
  • Inadequate safe drinking water
  • Poor sanitation
  • Infectious disease
  • Noncommunicable Diseases (NCDs)
  • Malnutrition
  • High infant mortality

Categories

Copyright © 2022 · News Pro On Genesis Framework · WordPress · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
Cookie settingsACCEPTACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.